OverviewChartProfileKey statisticsFinancialsTechnicalNewsTraderScreen

Exelixis Inc/  US30161Q1040  /

NASDAQ
29/05/2024  22:00:00 Chg. +0.1500 Volume Bid01:58:29 Ask01:58:29 High Low
20.4900USD +0.74% 1.87 mill.
Turnover: 27.76 mill.		 20.2000Bid Size: 200 20.6000Ask Size: 500 20.5950 20.1400
GlobeNewswire 09/05 Royalty Pharma Reports First Quarter 2024 Results
GlobeNewswire 01/05 Giants of Cancer Care® Announces the 12th Annual Class of Inductees
GlobeNewswire 29/03 Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire 04/03 Osmol Therapeutics Appoints Ron Weitzman, M.D., as Interim Chief Medical Officer
GlobeNewswire 15/02 Royalty Pharma Reports Q4 and Full Year 2023 Results
GlobeNewswire 14/02 Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focu...
GlobeNewswire 06/02 Cybrexa Regains Rights to CBX-12
GlobeNewswire 08/01 XOMA Names Owen Hughes as Chief Executive Officer and Appoints Jack L. Wyszomierski as Chairman of t...
GlobeNewswire 04/01 Sensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming Milestones
GlobeNewswire 26/12/2023 Harpoon Therapeutics Strengthens Leadership Team
GlobeNewswire 11/12/2023 Ryvu Therapeutics Presents Data on RVU120 at the 2023 American Society of Hematology (ASH) Annual Me...
GlobeNewswire 07/12/2023 Ryvu Therapeutics Presents Data on RVU120 at the San Antonio Breast Cancer Symposium 2023
GlobeNewswire 29/11/2023 Ryvu Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
GlobeNewswire 15/11/2023 Mural Oncology Launches to Advance Pipeline of Novel Engineered Cytokine Immunotherapies
GlobeNewswire 08/11/2023 Royalty Pharma Reports Third Quarter 2023 Results
GlobeNewswire 01/11/2023 Dr. Hartmut Tintrup joins Cellbox Solutions GmbH as new CEO
GlobeNewswire 23/10/2023 Ryvu Therapeutics Provides an Update on the Progress of RVU120 Phase I Studies in Patients with Soli...
GlobeNewswire 17/10/2023 Olema Oncology Appoints Oncology Biotech Executive Scott Garland to Board of Directors
GlobeNewswire 04/10/2023 Ryvu Therapeutics to Present Preclinical Data on PRMT5 and its Synthetic Lethality Platform at the 2...
GlobeNewswire 13/09/2023 Ryvu Therapeutics Reports 2023 Half-Year Financial Results and Provides Corporate Update
GlobeNewswire 31/08/2023 Adagene Reports Six Month Financial Results for 2023 and Provides Corporate Update
GlobeNewswire 21/08/2023 Exelixis and Ipsen Announce Positive Results from Phase 3 CONTACT-02 Pivotal Trial Evaluating Caboza...
GlobeNewswire 15/02/2022 Royalty Pharma Reports Q4 and Full Year 2021 Results
GlobeNewswire 18/01/2022 Fountain Therapeutics Announces Appointment of Anupama Hoey as Chief Business Officer
GlobeNewswire 22/12/2021 Adagene Achieves Key Milestone in Collaboration with Exelixis for SAFEbody® Novel Masked Antibody-Dr...